Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

1.710

-0.060 (-3.39%)

At close: Feb 27, 2026, 4:00 PM EST

1.720

+0.010 (0.58%)

After-hours: Feb 27, 2026, 7:51 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Developing and Commercializing CAR-T Therapies	10.12M	1.70M	6.36M	2.33M	1.72M
Developing and Commercializing CAR-T Therapies Growth	496.00%	-73.30%	172.96%	35.86%	-41.02%
Total	10.12M	1.70M	6.36M	2.33M	1.72M
Total Growth	496.00%	-73.30%	172.96%	35.86%	-41.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
United States of America	-	1.35M	6.19M	1.51M	-
United States of America Growth	-	-78.17%	311.02%	-	-
Europe	10.12M	-	-	-	-
United Kingdom	-	346.00K	-	-	242.00K
Total	10.12M	1.70M	6.19M	1.51M	242.00K
Total Growth	496.00%	-72.59%	311.02%	522.73%	-

Source: S&P Global Market Intelligence.